miR-9 ectopic expression decreased the ID2 level in MCF7 breast cancer cells (not shown), suggesting that the discrepancy, at least in the case of miR-9, is unlikely to result from the inability to target ID2 in breast cancer cells and may be explained by the opposite role of ID2 in the two cell types, at least partly. This evidence concerns the gene ID2 and breast carcinoma.